SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,578 | -43.5% | 343 | -46.7% | 0.02% | -41.7% |
| Q2 2023 | $73,636 | -16.9% | 643 | 0.0% | 0.04% | -23.4% |
| Q1 2023 | $88,625 | +6.4% | 643 | 0.0% | 0.05% | -2.1% |
| Q4 2022 | $83,320 | +17.4% | 643 | 0.0% | 0.05% | +14.3% |
| Q3 2022 | $71,000 | +16.4% | 643 | -20.7% | 0.04% | +10.5% |
| Q2 2022 | $61,000 | -34.4% | 811 | -32.0% | 0.04% | -17.4% |
| Q1 2022 | $93,000 | -10.6% | 1,193 | +3.0% | 0.05% | -6.1% |
| Q4 2021 | $104,000 | -14.0% | 1,158 | -11.5% | 0.05% | -35.5% |
| Q3 2021 | $121,000 | +23.5% | 1,308 | +4.0% | 0.08% | +26.7% |
| Q2 2021 | $98,000 | +11.4% | 1,258 | +7.1% | 0.06% | -7.7% |
| Q1 2021 | $88,000 | -13.7% | 1,175 | +95.8% | 0.06% | -22.6% |
| Q4 2020 | $102,000 | +21.4% | 600 | 0.0% | 0.08% | +1.2% |
| Q3 2020 | $84,000 | – | 600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |